glembatumumab
antiantibody
idiospecific
booster injection
ziltivekimab
retifanlimab
booster dose
monoclonal
booster shot
sasanlimab
zenocutuzumab
immunoreactivity
pozelimab
immunobinding
dinutuximab
immunoantigen
sintilimab
solitomab
toripalimab
vanucizumab
muromonab
alloantibody
heterophile
atezolizumab
olaratumab
brolucizumab
immunosorbance
pidilizumab
monoantibody
abagovomab
immunosorbing
polytypic
antiidiotypic
ravulizumab
tislelizumab
immunofiltration
-mab
countercorrelated
radioimmunoprecipitation
serofast
gevokizumab
radioimmunoelectrophoresis
heteroclitic antibody
gamma globulin
ABO antibodies
immunocharacterize
cross-reactivity
xenoimmunization